GENNARELLI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 21.011
AS - Asia 10.322
EU - Europa 8.474
SA - Sud America 2.178
AF - Africa 238
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 1
Totale 42.279
Nazione #
US - Stati Uniti d'America 20.639
CN - Cina 3.721
SG - Singapore 3.272
UA - Ucraina 1.999
BR - Brasile 1.792
IT - Italia 1.247
HK - Hong Kong 1.148
PL - Polonia 1.124
DE - Germania 1.095
FR - Francia 774
VN - Vietnam 765
FI - Finlandia 605
GB - Regno Unito 555
TR - Turchia 372
RU - Federazione Russa 334
IE - Irlanda 328
BD - Bangladesh 302
IN - India 233
CA - Canada 180
AR - Argentina 163
MX - Messico 109
ZA - Sudafrica 80
IQ - Iraq 70
ID - Indonesia 68
SE - Svezia 65
NL - Olanda 57
EC - Ecuador 56
ES - Italia 54
PK - Pakistan 51
JP - Giappone 45
BE - Belgio 43
CZ - Repubblica Ceca 42
AT - Austria 41
CO - Colombia 38
VE - Venezuela 38
SA - Arabia Saudita 37
MA - Marocco 34
CL - Cile 32
PY - Paraguay 28
AU - Australia 27
NG - Nigeria 26
KE - Kenya 24
UZ - Uzbekistan 24
CH - Svizzera 22
IR - Iran 22
EU - Europa 21
JO - Giordania 21
LT - Lituania 20
EG - Egitto 18
JM - Giamaica 18
PE - Perù 15
PH - Filippine 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
IL - Israele 14
NP - Nepal 14
KR - Corea 12
TT - Trinidad e Tobago 11
AZ - Azerbaigian 10
BG - Bulgaria 10
BH - Bahrain 10
CR - Costa Rica 10
KZ - Kazakistan 10
UY - Uruguay 10
DZ - Algeria 9
HN - Honduras 9
KG - Kirghizistan 9
MY - Malesia 9
OM - Oman 9
PA - Panama 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
MU - Mauritius 8
AL - Albania 7
HU - Ungheria 7
RO - Romania 7
TW - Taiwan 7
SV - El Salvador 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
BY - Bielorussia 5
GE - Georgia 5
KW - Kuwait 5
LV - Lettonia 5
PT - Portogallo 5
AO - Angola 4
GT - Guatemala 4
LU - Lussemburgo 4
NI - Nicaragua 4
NO - Norvegia 4
PS - Palestinian Territory 4
TH - Thailandia 4
BB - Barbados 3
CI - Costa d'Avorio 3
DK - Danimarca 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
LY - Libia 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 42.249
Città #
Fairfield 2.491
Woodbridge 1.991
Singapore 1.803
Ashburn 1.757
Jacksonville 1.432
Houston 1.289
Hong Kong 1.141
Warsaw 1.118
Ann Arbor 1.076
Cambridge 1.008
Seattle 945
Wilmington 831
San Jose 714
Chandler 654
Beijing 636
Princeton 602
The Dalles 592
Nanjing 517
New York 429
Los Angeles 335
Dublin 323
Brescia 322
Lauterbourg 304
Istanbul 293
Helsinki 288
Ho Chi Minh City 267
Dearborn 230
Nanchang 212
Des Moines 206
Munich 171
Buffalo 165
São Paulo 165
Milan 157
Shenyang 157
Changsha 143
Hebei 139
Hanoi 138
San Diego 133
Moscow 126
Shanghai 121
Redondo Beach 115
Council Bluffs 111
Chicago 109
Lancaster 107
San Francisco 106
Jinan 104
Dallas 99
Tianjin 94
Jiaxing 86
Santa Clara 83
London 75
Orem 75
Dong Ket 68
Verona 67
Hangzhou 65
Kunming 64
Turku 61
Frankfurt am Main 60
Norwalk 57
Boardman 56
Guangzhou 53
Rio de Janeiro 53
Nuremberg 52
Zhengzhou 52
Toronto 51
Brooklyn 50
Lanzhou 50
Rome 49
Montreal 48
Ningbo 48
Belo Horizonte 47
Mexico City 45
Johannesburg 44
Brussels 42
Haikou 39
Tokyo 39
Atlanta 37
Haiphong 36
Denver 35
Romola 34
San Mateo 34
Bolzano 33
Phoenix 31
Brasília 30
Chennai 30
Jakarta 30
Stockholm 29
Leawood 27
Naples 27
Washington 27
Brno 26
Abuja 25
Dhaka 25
Porto Alegre 25
Campinas 24
Kocaeli 24
Manchester 24
Mumbai 24
Charlotte 23
Da Nang 23
Totale 28.528
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 323
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 320
New Copy Number Variations in Schizophrenia 318
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 301
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 264
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 253
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 252
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 236
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 232
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 230
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 228
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 226
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients 218
New biological pathways for major depression: gene expression decomposition in G x E components 211
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 209
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 208
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 207
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. 203
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 198
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 194
The role of the potassium channel gene KCNK2 in major depressive disorder 193
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 187
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 186
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 185
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. 184
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 183
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 181
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. 181
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 179
The role of GRIK4 gene in treatment-resistant depression 179
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 178
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 178
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. 176
Analysis of Copy Number Variations in Schizophrenia Italian Patients 173
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. 173
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 173
Glucose metabolism alterations in patients with bipolar disorder 173
Next Generation Sequencing Analysis in Early Onset Dementia Patients 172
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. 172
A genome-wide investigation of SNPs and CNVs in schizophrenia. 171
BDNF Val66Met polymorphism and protein levels in amniotic fluid. 171
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets' 170
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 170
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 168
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 168
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 167
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. 165
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. 165
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 165
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 164
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 164
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study 163
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 160
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 159
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 159
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine. 158
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 158
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. 155
Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. 155
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 154
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 154
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 154
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 152
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 152
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 151
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial. 150
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 149
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 149
Immune and metabolic alterations in first episode psychosis (FEP) patients 148
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 148
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. 148
Heterozygous TREM2 mutations in frontotemporal dementia 147
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 147
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 146
VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome. 145
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 145
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). 145
Erbb3 leukocytes mRNA levels as biomarker of Major Depression. 145
Exome sequencing of schizophrenia patients with high level of homozygosity identifies a homozygous novel mutation that reduces the glutamate acid decarboxylase 67 (GAD67) activity 145
PCLO gene: Its role in vulnerability to major depressive disorder. 144
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 144
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence. 143
The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment 143
Blood microRNA changes in depressed patients during antidepressant treatment. 143
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 143
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 143
Dementia, delusions and seizures: storage disease or genetic AD? 142
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 142
INFLAMMATORY AND NEUROTROPHIC FACTORS UNBALANCE IN LEUKOCYTES OF FIRST EPISODE PSYCHOSIS PATIENTS 141
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 141
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment. 141
A single polymerase chain reaction-based protocol for detecting normal and expanded alleles in myotonic dystrophy. 140
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 139
Genetic variations and association. 139
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. 138
Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients 138
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 138
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 137
Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response 136
Influence of GRIK4 genetic variants on the electroconvulsive therapy response 136
Totale 17.437
Categoria #
all - tutte 205.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.821


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 0 0 0 0 0 0 0 0 0 0 210
2021/20222.396 158 541 56 56 14 98 206 142 172 238 206 509
2022/20232.084 349 12 31 146 190 620 6 208 315 32 94 81
2023/20242.135 127 52 188 131 95 349 60 72 588 37 37 399
2024/20255.439 47 55 82 615 592 516 392 189 513 585 1.034 819
2025/202611.645 1.042 1.622 852 1.769 1.142 762 1.602 471 725 930 497 231
Totale 42.814